Login
TILRAY INC
TILRAY
Updated on 26 Nov 2021 (End of trading day)
| Last (USD): 10.570 | Change: -0.330 | High: 10.730 | Remarks: - |
| Change (%): -3.03 | Low: 10.300 |
Loading search items...
Mode - Streaming
Switch to Static Mode?
Price Highlight
Index Highlight
STI
3,166.3
-55.2 (-1.72%)
-
STI Straits Times Index
3,166.3-55.2 (-1.72%) -
KLCI FTSE Bursa Malaysia KLCI
1,512.2-5.4 (-0.35%)Index delayed 15 minutes -
HSI Hang Seng Index
24,080.5-659.6 (-2.67%)Index delayed 15 minutes -
SSE SSE Composite Index
3,564.1-20.1 (-0.56%)Index delayed 15 minutes -
N225 Nikkei 225
28,751.6-747.7 (-2.53%)Index delayed 20 minutes -
JCI Jakarta Composite Index
6,561.6-137.8 (-2.06%)Index delayed 10 minutes
- Volume: 1,737.0M
- Value: 1,744.7M
- Rise: 72
- Fall: 305
- Unch: 381
Intraday Market Ticker Help
| Time | Name | Type | Price | Vol |
|---|
-
Top Active
-
Top Gainer
-
Top Loser
| Name | Last | Change |
|---|---|---|
| 0.021 | -0.004 | |
| 0.084 | -0.001 | |
| 0.400 | +0.110 | |
| 0.795 | -0.035 | |
| 0.695 | -0.020 | |
| 0.006 | -0.002 | |
| 2.440 | -0.030 | |
| 0.022 | +0.001 | |
| 1.550 | -0.020 | |
| 0.061 | - |
World Indices
| Name | Last | Change |
|---|---|---|
| Nasdaq | 15,491.7 | -353.6 |
| HSI | 24,080.5 | -659.6 |
| HSCEI | 8,576.1 | -233.7 |
| Jakarta | 6,561.6 | -137.8 |
| Nikkei 225 | 28,751.6 | -747.7 |
| SSE Comp | 3,564.1 | -20.1 |
| Shanghai A | 3,735.3 | -21.1 |
| Shanghai B | 281.0 | -1.2 |
| KOSPI | 2,936.4 | -43.8 |
Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.
Fundamental - Factsheet
Help-
Factsheet
Free TrialCompany Background
Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in New York, NY.
Key Statistics
| EPS (USD) a | -0.79299 | Trailing EPS (USD) b | -0.79299 | NAV (USD) c | 9.3225 |
|---|---|---|---|---|---|
| PE a | - | Trailing PE d | - | Price / NAV c | 1.1338 |
| Dividend Yield (%) e | - | Cash In Hand (USD) f | 0.8121 | Issued & Paid-up Shares g | 463,336,000 |
| Piotroski F Score | 4 | Market Cap (M) | 4,897.462 | Free Float (%) | 95.7 |
| Return on Equity (ROE) (%) h | n.m. | Revenue Growth (%) TTM i | 143.767 | ||
| Net Earnings Growth (%) j | -35.543 | Net Debt/Equity k | 0.101 | ||
| Sector & Industry | Process Industries - Agricultural Commodities/Milling | ||||
Notes:
-
Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 15 Oct 2021. Please click here for more information.
-
Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
-
Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
-
Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
-
Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)
Total Shareholder Return
| Period | Dividend Received | Capital Appreciation | Total Shareholder Return | |||
|---|---|---|---|---|---|---|
| Short Term Return | 5 Days | - | -0.360 | -3.29 % | ||
| 10 Days | - | -2.370 | -18.32 % | |||
| 20 Days | - | +0.270 | +2.62 % | |||
| Medium Term Return | 3 Months | - | -2.850 | -21.24 % | ||
| 6 Months | - | -6.100 | -36.59 % | |||
| 1 Year | - | +2.070 | +24.35 % | |||
| Long Term Return | 2 Years | - | -9.270 | -46.72 % | ||
| 3 Years | - | -91.880 | -89.68 % | |||
| Annualised Return | Annualised | - | - | -53.10 % | ||
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.